Ellipse Intramedullary Nail High Tibial Osteotomy Study
NCT ID: NCT02412163
Last Updated: 2017-09-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
41 participants
OBSERVATIONAL
2015-07-31
2016-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ellipse Intramedullary High Tibial Osteotomy Nail Study
NCT02519218
Study of Subtalar Arthrodesis Using AlloStem® Versus Autologous Bone Graft
NCT01413061
Relevance of Osteochondral Lesions in Ankle Microinstability
NCT06947317
Clinical-MRI Evaluation in Patients Undergoing Subtalar Arthrorisis With Reabsorbable Endorthesis Implant in PLLA
NCT06525532
Arcos Revision Stem: Evaluation of Clinical Performance
NCT01820611
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The Ellipse IM HTO Nail is used in valgizing HTO procedures to correct varus malalignment. The Ellipse IM HTO Nail is surgically placed in the intramedullary canal of the tibia. It is lengthened telescopically using the non-invasive external remote control.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
IM HTO Nail
Implant with the Ellipse IM HTO Nail
Ellipse IM HTO Nail
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ellipse IM HTO Nail
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patient is diagnosed with current osteoarthritis of the knee
3. Patient is eighteen years of age or greater
4. Patient is a candidate to be implanted with an Ellipse IM HTO System
5. If female of childbearing potential, patient presents with a negative pregnancy test and agrees to employ adequate birth control measures for the duration of the study
6. Patient understands and accepts the obligation to comply with the required follow-up visits and is logistically able to meet all study requirements
7. Patient signs informed consent for the use of their personal private data
Exclusion Criteria
2. Varus deformity greater than 10°
3. Flexion contracture greater than 15°
4. Knee flexion under 90°
5. Medial/lateral tibial subluxation over 1 cm
6. Medial bone loss of over 3 mm
7. Inflammatory arthritis
8. Arthritis in the lateral compartment
9. Patella baja
10. Weight over 114 kg
11. Severe patellofemoral symptoms
12. Unaddressed ligamentous instability
13. Fixed flexion contracture
14. Known or suspected osteoporosis or osteopenia based on medical history and radiographic images
15. Current use of nicotine products.
16. Requires other surgical procedures at the time of the HTO surgery
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ellipse Technologies, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mark T Dahl, MD
Role: PRINCIPAL_INVESTIGATOR
University of Minnesota
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medizinische Hochschule
Hanover, , Germany
Martini Ziekenhuis
Groningen, , Netherlands
Isala Klinieken
Zwolle, , Netherlands
Centrum Ortopedii I Traumatologii
Bialystok, , Poland
Zagiel Hospital
Lublin, , Poland
Lekmed Hospital
Warsaw, , Poland
District Hospital of Wolomin
Wołomin, , Poland
North Bristol NHS Trust
Bristol, , United Kingdom
North Cumbria University Hospital
Carlisle, , United Kingdom
University Hospital Aintree
Liverpool, , United Kingdom
University Hospitals Southampton
Southampton, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PR0123
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.